Dennis E Hallahan

Nashville, TN, United States of America

Dennis E Hallahan

USPTO Granted Patents = 34 

 


Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 327(Granted Patents)


Location History:

  • Des Plaines, IL (US) (2002)
  • Chicago, IL (US) (1997 - 2006)
  • Park Ridge, IL (US) (1997 - 2009)
  • Nashville, TN (US) (2000 - 2014)
  • St. Louis, MO (US) (2013 - 2022)

Company Filing History:


Years Active: 1997-2022

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: Dennis E. Hallahan: Innovator in Cancer Therapy

Introduction

Dennis E. Hallahan is a prominent inventor based in Nashville, TN, recognized for his significant contributions to cancer research and therapy. With a remarkable portfolio of 34 patents, Hallahan has pioneered innovative approaches to tumor treatments, enhancing methods of drug delivery specific to cancer cells.

Latest Patents

Some of Hallahan's latest patents include "Antibodies to TIP1 and methods of use thereof," which disclose antigen binding proteins that aid in recognizing tumor cells and facilitate the targeted delivery of therapeutic drugs. Another notable recent invention is "Compositions targeting radiation-induced molecules and methods of use thereof," focusing on peptide constructs that bind to GRP78, thus benefiting treatments involving radiation therapy.

Career Highlights

Over the years, Hallahan has made significant strides in his field while working at esteemed institutions such as Vanderbilt University and Washington University. His extensive research endeavors have established him as a leader in creating innovative solutions for cancer treatment.

Collaborations

Throughout his career, Hallahan has collaborated with esteemed colleagues, including Ralph R. Weichselbaum and Donald W. Kufe. These partnerships have contributed to the advancement of his research, fostering an environment that encourages innovation and discovery in the realm of oncology.

Conclusion

Dennis E. Hallahan's work exemplifies the importance of innovation in medicine, particularly in the fight against cancer. With his numerous patents and collaborative efforts, he continues to shape the future of therapeutic strategies, aiming to improve patient outcomes and advance oncological science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…